ACCESSION: MSBNK-SMB_Measured-HSA015P0250001
RECORD_TITLE: Characterized; 2,4,6-triallyloxy-1,3,5-triazine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL03_pos_9377': {'bp': 728809.0, 'sum': 4476963.0}, 'Blanc1-pos_9853': {'bp': 477813.0, 'sum': 1971091.0}, 'EL22_pos_9585': {'bp': 155607.0, 'sum': 777782.0}, 'EL12_pos_9525': {'bp': 153221.0, 'sum': 744816.0}, 'EL23_pos_9489': {'bp': 144516.0, 'sum': 692238.0}, 'EL04_pos_9471': {'bp': 129070.0, 'sum': 628789.0}, 'EL01_pos_9471': {'bp': 127151.0, 'sum': 638481.0}, 'EL13_pos_9495': {'bp': 125432.0, 'sum': 613923.0}, 'EL19_pos_9561': {'bp': 124648.0, 'sum': 647736.0}, 'EL15_pos_9513': {'bp': 115387.0, 'sum': 589167.0}, 'EL20_pos_9484': {'bp': 115303.0, 'sum': 584269.0}, 'EL02_pos_9567': {'bp': 108116.0, 'sum': 624448.0}, 'EL05_pos_9543': {'bp': 107653.0, 'sum': 574826.0}, 'Blanc2-pos_9393': {'bp': 107252.0, 'sum': 513340.0}, 'EL09_pos_9489': {'bp': 106633.0, 'sum': 584195.0}, 'EL17_pos_9501': {'bp': 105895.0, 'sum': 555653.0}, 'EL21_pos_9503': {'bp': 103518.0, 'sum': 533923.0}, 'EL14_pos_9502': {'bp': 102611.0, 'sum': 567932.0}, 'EL24_pos_9478': {'bp': 102550.0, 'sum': 521229.0}, 'EL18_pos_9479': {'bp': 94016.0, 'sum': 507547.0}, 'EL11_pos_9473': {'bp': 92288.0, 'sum': 475283.0}, 'EL08_pos_9477': {'bp': 89420.0, 'sum': 455919.0}, 'EL16_pos_9483': {'bp': 84014.0, 'sum': 448237.0}, 'Blanc3-pos_9411': {'bp': 80256.0, 'sum': 400672.0}}
COMMENT: RETENTION_TIME_STDEV 0.037
COMMENT: PRECURSOR_M/Z_RAW 250.118748
COMMENT: PRECURSOR_M/Z_STDEV 0.000079
COMMENT: PRECURSOR_IN_MS1 mz 250.118679; int 75.914; delta(ppm) 1.196827
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.233; C12H15N3O3; [M+H]+; delta(ppm) 0.232828
COMMENT: PROPOSED_MF MS-FINDER 3.198; C12H15N3O3; [M+H]+; delta(ppm) 0.228697
COMMENT: PROPOSED_MF MS-FINDER 1.906; C5H15N9OS; [M+H]+; delta(ppm) -2.513197
COMMENT: PROPOSED_MF MS-FINDER 1.849; C6H16N7O2P; [M+H]+; delta(ppm) 4.360996
COMMENT: PROPOSED_MF SIRIUS5_Sirius 55.565; C12H15N3O3; [M+H]+; delta(ppm) 0.228697
COMMENT: PROPOSED_MF SIRIUS5_Sirius 44.049; C11H20ClNO3; [M+H]+; delta(ppm) -87559.221223
COMMENT: PROPOSED_MF SIRIUS5_Sirius 43.397; C10H20NO4P; [M+H]+; delta(ppm) -6.375194
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C12H15N3O3; [M+H]+; delta(ppm) 0.228697
COMMENT: PROPOSED_MF SIRIUS6_Sirius 116.624; C12H15N3O3; [M+H]+; delta(ppm) 0.228697
COMMENT: PROPOSED_MF SIRIUS6_Sirius 112.011; C9H16FN3O4; [M+H]+; delta(ppm) -4.339731
COMMENT: PROPOSED_MF SIRIUS6_Sirius 101.372; C11H20ClNO3; [M+H]+; delta(ppm) -87559.221223
COMMENT: PROPOSED_MF SIRIUS6_Sirius 100.834; C10H20NO4P; [M+H]+; delta(ppm) -6.375194
COMMENT: PROPOSED_MF SIRIUS6_Sirius 98.167; C14H17O4; [M+H]+; delta(ppm) -5.139383
COMMENT: PROPOSED_MF SIRIUS6_Sirius 90.213; C10H13N6O2; [M+H]+; delta(ppm) 5.596835
COMMENT: PROPOSED_MF SIRIUS6_Sirius 78.689; C9H17F2N3OSi; [M+H]+; delta(ppm) -203601.758766
COMMENT: PROPOSED_MF SIRIUS6_Sirius 75.959; C7H15F4N3O2; [M+H]+; delta(ppm) 5.436742
COMMENT: PROPOSED_MF SIRIUS6_Sirius 69.415; C6H15BN4O6; [M+H]+; delta(ppm) 41699.171036
COMMENT: PROPOSED_MF SIRIUS6_Sirius 69.140; C8H20FN3OSi2; [M+H]+; delta(ppm) -203606.830570
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.994; C12H15N3O3; [M+H]+; delta(ppm) 0.228697
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.006; C9H16FN3O4; [M+H]+; delta(ppm) -4.339731
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 8.000; BJELTSYBAHKXRW-UHFFFAOYSA-N; C12H15N3O3; Spectral Match to 2,4,6-Triallyloxy-1,3,5-triazine from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; KOMNUTZXSVSERR-UHFFFAOYSA-N; C12H15N3O3; 1,3,5-triprop-2-enyl-1,3,5-triazaperhydroine-2,4,6-trione CollisionEnergy:205060
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.200; KQYAFKZHQIMQMF-ZROIWOOFSA-N; [M+H]+; CCOC(=O)CC(=NNC(=O)C1=CC=NC=C1)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.198; BJELTSYBAHKXRW-UHFFFAOYSA-N; [M+H]+; C=CCOC1=NC(OCC=C)=NC(OCC=C)=N1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.189; ZNDDVCUMPVORDL-UHFFFAOYSA-N; [M+H]+; O=C([O-])C(C(=O)CCC)CC(Cl)[N+](C)(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.128; JLQIHKUMTLIZFT-UHFFFAOYSA-N; [M+H]+; O=C1N=C(N)N(C)C1CC2=CC=C(O)C(OC)=C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.101; JEAWJOAWWCISHO-UHFFFAOYNA-N; [M+H]+; O=NC=C1NC=C(C=C1)C(=O)NCC1CCCO1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.021; PUARYECATSVDEK-WYVADAIZNA-N; [M+H]+; Siderochelin C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.021; RAOCRURYZCVHMG-UHFFFAOYSA-N; [M+H]+; N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.934; TVWVXIWYFXAZHZ-JLDDOWRYNA-N; [M+H]+; NI 15501A
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.928; JLQIHKUMTLIZFT-UHFFFAOYSA-N; [M+H]+; 2-amino-5-[(4-hydroxy-3-methoxyphenyl)methyl]-1-methyl-4,5-dihydro-1H-imidazol-4-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.839; IYPSTHRLADYWFK-UHFFFAOYSA-N; [M+H]+; methyl 1-(pyridine-3-carbonyl)piperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.832; MYMNCVVFLLRVNW-UHFFFAOYSA-N; [M+H]+; methyl 4-(pyridine-3-carbonyl)piperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.816; JEAWJOAWWCISHO-UHFFFAOYNA-N; [M+H]+; 6-(nitrosomethylidene)-N-(2-oxolanylmethyl)-1H-pyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.788; BJELTSYBAHKXRW-UHFFFAOYSA-N; [M+H]+; 2,4,6-triallyloxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.782; GSTWJGHEEBKDPK-UHFFFAOYSA-N; [M+H]+; N-(4-nitrophenyl)-2-(1-pyrrolidinyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.770; KQYAFKZHQIMQMF-ZROIWOOFSA-N; [M+H]+; ethyl (3Z)-3-(pyridine-4-carbonylhydrazinylidene)butanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.749; KOMNUTZXSVSERR-UHFFFAOYSA-N; [M+H]+; 1,3,5-triallyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.726; FYBFGAFWCBMEDG-UHFFFAOYSA-N; [M+H]+; hexahydro-1,3,5-tris(1-oxoallyl)-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; GSTWJGHEEBKDPK-UHFFFAOYSA-N; [M+H]+; N-(4-nitrophenyl)-2-(1-pyrrolidinyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.973; KOMNUTZXSVSERR-UHFFFAOYSA-N; [M+H]+; 1,3,5-triallyl-1,3,5-triazine-2,4,6(1H,3H,5H)-trione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.877; BJELTSYBAHKXRW-UHFFFAOYSA-N; [M+H]+; 2,4,6-triallyloxy-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.823; MYMNCVVFLLRVNW-UHFFFAOYSA-N; [M+H]+; methyl 4-(pyridine-3-carbonyl)piperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.804; IYPSTHRLADYWFK-UHFFFAOYSA-N; [M+H]+; methyl 1-(pyridine-3-carbonyl)piperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.772; RAOCRURYZCVHMG-UHFFFAOYSA-N; [M+H]+; N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.736; JEAWJOAWWCISHO-UHFFFAOYNA-N; [M+H]+; 6-(nitrosomethylidene)-N-(2-oxolanylmethyl)-1H-pyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.703; KQYAFKZHQIMQMF-ZROIWOOFSA-N; [M+H]+; ethyl (3Z)-3-(pyridine-4-carbonylhydrazinylidene)butanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.613; JLQIHKUMTLIZFT-UHFFFAOYSA-N; [M+H]+; 2-amino-5-[(4-hydroxy-3-methoxyphenyl)methyl]-1-methyl-4,5-dihydro-1H-imidazol-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.602; PUARYECATSVDEK-WYVADAIZNA-N; [M+H]+; Siderochelin C
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.600; FYBFGAFWCBMEDG-UHFFFAOYSA-N; [M+H]+; hexahydro-1,3,5-tris(1-oxoallyl)-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.580; TVWVXIWYFXAZHZ-JLDDOWRYNA-N; [M+H]+; NI 15501A
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.711; RAOCRURYZCVHMG-UHFFFAOYSA-N; [M+H]+; methyl N-(6-propoxy-1H-benzimidazol-2-yl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.384; KOMNUTZXSVSERR-UHFFFAOYSA-N; [M+H]+; 1,3,5-tris(prop-2-enyl)-1,3,5-triazinane-2,4,6-trione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.256; BJELTSYBAHKXRW-UHFFFAOYSA-N; [M+H]+; 2,4,6-tris(prop-2-enoxy)-1,3,5-triazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.269; FYBFGAFWCBMEDG-UHFFFAOYSA-N; [M+H]+; 1-[3,5-di(prop-2-enoyl)-1,3,5-triazinan-1-yl]prop-2-en-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; OPXZNLYIUMSHTF-UHFFFAOYSA-N; [M+H]+; 4-(hydroxymethyl)-1-phenyl-2-propan-2-yl-1,2,4-triazolidine-3,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.876; FTNDZQVIQZUANZ-UHFFFAOYSA-N; [M+H]+; 3-(2-morpholin-4-ylethyl)-[1,3]oxazolo[4,5-b]pyridin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; IIFSCIZSLDBHOT-UHFFFAOYSA-N; [M+H]+; 1-(6-carbamoylpyridin-2-yl)piperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.773; QUZMCJMGHMRZHA-UHFFFAOYSA-N; [M+H]+; 1-[4-(4-nitrophenyl)piperazin-1-yl]ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.749; VHAXHUSUMSLYQT-UKTHLTGXSA-N; [M+H]+; (2E)-2-(diethylhydrazinylidene)-1-(4-nitrophenyl)ethanone
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.667; BIZMXNOTUIAPLZ-UHFFFAOYSA-N; [M+H]+; 3-[2-(dimethylamino)ethyl]-2-oxo-1H-benzimidazole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.592; SOUVCKJJDSBWPC-UHFFFAOYSA-N; [M+H]+; N-(4,7-dimethoxy-1H-benzimidazol-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; XNCYVTKDNMFVND-VIZOYTHASA-N; [M+H]+; 2-[(E)-(4-carbamimidoylphenyl)methylideneamino]oxy-2-methylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.555; PTZZORNJUQNDTM-QDMIXUNLSA-N; [M+H]+; (E)-3-hydroxy-2-[(4-methoxyphenyl)diazenyl]-N-methylbut-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.474; GROCFHMUJRZPRZ-UHFFFAOYSA-N; [M+H]+; N-(5,6-dimethoxy-1H-benzimidazol-2-yl)propanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -37.906; BJELTSYBAHKXRW; [M+H]+; Activator OC
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -73.647; KOMNUTZXSVSERR; [M+H]+; Triallylisocyanurate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.016; FYBFGAFWCBMEDG; [M+H]+; Fixierer P
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.437; OPXZNLYIUMSHTF; [M+H]+; N-(Hydroxymethyl)-2-isopropyl-3-phenylbicarbamimide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -333.254; MADGGJXZXKOPDW; [M+H]+; 2,5-dimethoxy-4-morpholin-4-ylbenzenediazonium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -339.418; TVWVXIWYFXAZHZ; [M+H]+; 2-(2-acetamidopropanoylamino)benzamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -344.423; GSTWJGHEEBKDPK; [M+H]+; N-(4-nitrophenyl)-2-pyrrolidinylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.103; PTZZORNJUQNDTM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -359.227; VHAXHUSUMSLYQT; [M+H]+; 4-Nitrophenylglyoxal N,N-diethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.230; HBZFZKSPJVDGJV; [M+H]+; Azidofibrate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -378.900; RAOCRURYZCVHMG; [M+H]+; Loditac
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -389.883; KRXLHSGWNOLBTF; [M+H]+; (p-Toluyl-m-nitro)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -393.680; SOUVCKJJDSBWPC; [M+H]+; 5-25-13-00328 (Beilstein Handbook Reference)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -413.467; GROCFHMUJRZPRZ; [M+H]+; N-(5,6-Dimethoxy-2-benzimidazolyl)propionamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -441.817; FTNDZQVIQZUANZ; [M+H]+; 3-(2-Morpholinoethyl)oxazolo(4,5-b)pyridin-2(3H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -485.780; CBNJCZLIBCNXFP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -497.850; LINONVNNJPVOHW; [M+H]+; 2''-Deoxy-3,7-dideazaadenosine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -515.799; XNCYVTKDNMFVND; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -524.025; PUARYECATSVDEK; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -534.252; OKWDELZOYQDSQL; [M+H]+; 2-acetamido-3-(4-carbamimidoylphenyl)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -549.529; IYPSTHRLADYWFK; [M+H]+; methyl 1-nicotinoylpiperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -553.820; MYMNCVVFLLRVNW; [M+H]+; Methyl (2R)-4-(pyridine-3-carbonyl)piperazine-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -560.175; JLQIHKUMTLIZFT; [M+H]+; 2-imino-1-methyl-5-vanillyl-imidazolidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.661; BJELTSYBAHKXRW; [M+H]+; Activator OC
COMMENT: CONFIDENCE Level 3: Tentative candidate, 2,4,6-triallyloxy-1,3,5-triazine, BJELTSYBAHKXRW-UHFFFAOYSA-N; Matching to 8 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (7), MetFrag:MsfinderDB (3), MetFrag:PubchemLite (3);
CH$NAME: 2,4,6-triallyloxy-1,3,5-triazine
CH$NAME: 2,4,6-tris(prop-2-enoxy)-1,3,5-triazine
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C12H15N3O3
CH$EXACT_MASS: 249.111341
CH$SMILES: C=CCOC1=NC(=NC(=N1)OCC=C)OCC=C
CH$IUPAC: InChI=1S/C12H15N3O3/c1-4-7-16-10-13-11(17-8-5-2)15-12(14-10)18-9-6-3/h4-6H,1-3,7-9H2
CH$LINK: INCHIKEY BJELTSYBAHKXRW-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:7555
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 15.460
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 250.118675
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-003r-9220000000-1c821a79a9569759ce59
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0024449 56.4811 53.003143 0.8868 8.44 0.6462 23 f{C3H1O1}/4.79ppm,p-C9H15N3O2
  53.0388584 70.1404 53.039556 0.8861 9.26 0.8652 24 f{C4H5}/5.31ppm,p-C8H11N3O3
  55.0544540 33.2262 55.055162 1.1625 10.09 0.3913 22 f{C4H7}/4.13ppm,p-C8H9N3O3
  56.0133240 47.8912 56.014036 1.3211 7.81 0.8202 23 f{C2H2N1O1}/4.18ppm,p-C10H14N2O2
  57.0701489 311.7986 57.070865 0.4205 53.58 0.8974 24 f{C4H9}/4.77ppm,p-C8H7N3O3
  58.0653447 36.2360 58.066065 1.1883 6.81 0.7722 24 f{C3H8N1}/3.77ppm,p-C9H8N2O3
  67.0543998 41.7863 67.055141 0.8799 13.11 0.5313 24 f{C5H7}/2.58ppm,p-C7H9N3O3
  68.9972118 44.0726 68.997955 1.3044 8.18 0.8043 23 f{C3H1O2}/1.54ppm,p-C9H15N3O1
  69.0699618 54.9027 69.070705 1.0135 9.75 0.7233 23 f{C5H9}/1.23ppm,p-C7H7N3O3
  69.9924506 58.6541 69.993194 1.1001 9.95 0.7443 24 f{C2N1O2}/1.37ppm,p-C10H16N2O1
  79.0543107 468.3375 79.055043 0.2530 19.71 0.9843 24 f{C6H7}/1.06ppm,p-C6H9N3O3
  81.0699511 999.0000 81.070678 0.2590 0.00 1.0000 24 f{C6H9}/0.92ppm,p-C6H7N3O3
  82.0287997 71.6552 82.029523 0.9143 13.01 0.7035 24 f{C4H4N1O1}/0.73ppm,p-C8H12N2O2
  82.0732264 39.6102 82.073949 0.9382 8.25 0.8015 20 ?
  84.0444386 95.4226 84.045154 0.8329 15.01 0.7261 24 f{C4H6N1O1}/0.58ppm,p-C8H10N2O2
  87.0189486 136.3072 87.019651 1.0687 11.14 0.9313 24 f{C2H3N2O2}/0.52ppm,p-C10H13N1O1
  91.0542277 33.4372 91.054907 1.3179 8.41 0.7036 23 f{C7H7}/0.01ppm,p-C5H9N3O3
  93.0698459 54.1331 93.070513 1.3431 12.63 0.7421 23 f{C7H9}/-0.33ppm,p-C5H7N3O3
  95.0854508 42.5742 95.086103 1.2620 12.15 0.4726 22 f{C7H11}/-0.80ppm,p-C5H5N3O3
  97.0648293 71.2213 97.065466 0.9787 10.52 0.7569 23 f{C6H9O1}/0.39ppm,p-C6H7N3O2
  98.9842099 85.6294 98.984831 0.9597 18.05 0.5820 23 ?
  99.0189046 35.8540 99.019526 1.2321 7.98 0.6156 23 f{C3H3N2O2}/0.01ppm,p-C9H13N1O1
  105.0698802 32.7959 105.070444 1.0945 12.83 0.5353 20 f{C8H9}/0.03ppm,p-C4H7N3O3
  107.0855177 44.2388 107.086060 1.0085 12.12 0.5565 24 f{C8H11}/-0.08ppm,p-C4H5N3O3
  109.1011819 24.3947 109.101710 1.3840 6.24 0.6737 19 f{C8H13}/0.05ppm,p-C4H3N3O3
  119.0855907 35.0390 119.086039 1.2092 8.59 0.6316 20 f{C9H11}/0.54ppm,p-C3H5N3O3
  121.1011641 32.5814 121.101593 1.3955 9.13 0.5774 20 f{C9H13}/-0.10ppm,p-C3H3N3O3
  127.0502448 74.3126 127.050613 1.6371 10.41 0.8844 23 f{C5H7N2O2}/0.32ppm,p-C7H9N1O1
  130.0247608 85.1402 130.025095 1.2459 9.26 0.7987 21 f{C3H4N3O3}/0.33ppm,p-C9H12
  135.1168372 28.7088 135.117110 1.5246 9.93 0.2714 18 f{C10H15}/0.08ppm,p-C2H1N3O3
  149.0597495 39.2905 149.060048 1.5698 10.15 0.6488 22 f{C9H9O2}/0.29ppm,p-C3H7N3O1
  159.1168014 35.8401 159.117127 1.3449 9.59 0.5614 19 f{C12H15}/-0.16ppm,p-H1N3O3
  170.0560248 192.2388 170.056382 0.7586 23.67 0.8487 24 f{C6H8N3O3}/0.04ppm,p-C6H8
  177.1273181 126.4602 177.127696 1.3211 24.61 0.8191 24 f{C10H15N3}/7.17ppm,p-C2H1O3
  195.0652724 95.4942 195.065706 1.2611 21.70 0.7658 23 f{C8H9N3O3}/7.33ppm,p-C4H7
  205.1221319 51.0911 205.122570 1.3260 12.31 0.2039 21 f{C11H15N3O1}/5.70ppm,p-C1H1O2
  208.0716584 29.9927 208.072089 1.6052 6.82 0.6553 18 f{C9H10N3O3}/-0.04ppm,p-C3H6
  248.2372124 179.2104 248.237579 0.9185 48.83 0.0045 20 ?
  250.1775706 99.0952 250.177939 1.4789 26.04 -0.5925 20 ?
  251.1276386 282.5320 251.128008 0.8322 52.85 0.8026 24 ?
  251.2007731 32.3526 251.201142 1.3893 7.50 0.4387 17 ?
PK$NUM_PEAK: 41
PK$PEAK: m/z int. rel.int.
  53.002445 56.48 56
  53.038858 70.14 70
  55.054454 33.23 33
  56.013324 47.89 47
  57.070149 311.80 311
  58.065345 36.24 36
  67.054400 41.79 41
  68.997212 44.07 44
  69.069962 54.90 54
  69.992451 58.65 58
  79.054311 468.34 468
  81.069951 999.00 999
  82.028800 71.66 71
  82.073226 39.61 39
  84.044439 95.42 95
  87.018949 136.31 136
  91.054228 33.44 33
  93.069846 54.13 54
  95.085451 42.57 42
  97.064829 71.22 71
  98.984210 85.63 85
  99.018905 35.85 35
  105.069880 32.80 32
  107.085518 44.24 44
  109.101182 24.39 24
  119.085591 35.04 35
  121.101164 32.58 32
  127.050245 74.31 74
  130.024761 85.14 85
  135.116837 28.71 28
  149.059750 39.29 39
  159.116801 35.84 35
  170.056025 192.24 192
  177.127318 126.46 126
  195.065272 95.49 95
  205.122132 51.09 51
  208.071658 29.99 29
  248.237212 179.21 179
  250.177571 99.10 99
  251.127639 282.53 282
  251.200773 32.35 32
//
